Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Guess Stock Faces Critical Earnings Test

Dieter Jaworski by Dieter Jaworski
November 18, 2025
in Analysis, Consumer & Luxury, Earnings
0
Guess ? Stock
0
SHARES
109
VIEWS
Share on FacebookShare on Twitter

Fashion retailer Guess finds itself at a pivotal moment as it prepares to release third-quarter 2026 financial results this Tuesday. The upcoming earnings report arrives amid conflicting signals from market professionals and institutional investors, creating significant anticipation around the announcement.

Wall Street’s Cautious Stance

Market experts maintain a restrained outlook toward Guess shares despite the company’s recent performance. Currently, all five covering analysts unanimously recommend a “Hold” position on the stock. Their average price target sits at $16.75, slightly below the current trading level of $16.92.

Recent analyst actions underscore this cautious sentiment. Zacks Research downgraded the equity from “Strong Buy” to “Hold” just days ago, while Weiss Ratings affirmed its “Hold” recommendation in October. This consistent positioning suggests professionals await stronger evidence of sustained performance before becoming more bullish.

Previous Quarter Exceeded Expectations

The company’s most recent financial disclosure demonstrated impressive strength. In late August, Guess reported earnings of $0.26 per share, significantly surpassing the $0.16 consensus estimate. Revenue reached $772.94 million, exceeding the projected $758.72 million and representing a 5.5% year-over-year increase.

Should investors sell immediately? Or is it worth buying Guess ??

This positive surprise sets a challenging benchmark for the upcoming report, where analysts project earnings of $0.23 per share on revenue of $767.9 million.

Institutional Money Flows Tell Different Story

Contrasting with analyst skepticism, institutional investors have demonstrated growing interest in Guess:

  • Corient Private Wealth LLC established a $205,000 position during the second quarter
  • Quadrant Capital Group LLC initiated a $136,000 investment in the third quarter
  • Both Brown Advisory Inc. and Cerity Partners LLC entered positions in Q2 with investments of $128,000 and $134,000 respectively

This institutional accumulation creates an intriguing dynamic where professional money managers appear more confident than research analysts.

The fashion company’s shares now trade at the intersection of these conflicting perspectives. Tuesday’s earnings release will determine whether the cautious analysts or optimistic institutions have correctly assessed Guess’s trajectory.

Ad

Guess ? Stock: Buy or Sell?! New Guess ? Analysis from February 7 delivers the answer:

The latest Guess ? figures speak for themselves: Urgent action needed for Guess ? investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Guess ?: Buy or sell? Read more here...

Tags: Guess ?
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
Altria Stock

Altria Faces Mounting Pressure in US Oral Tobacco Market

Almonty Stock

Almonty Secures Strategic Foothold in US Critical Minerals Market

Omv Stock

OMV Shares Face Conflicting Signals as Management and Analysts Clash

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com